Bivin & Associates’s Moderna MRNA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2022
Q2
$4K Hold
30
﹤0.01% 197
2022
Q1
$5K Sell
30
-86
-74% -$14.3K ﹤0.01% 209
2021
Q4
$29K Buy
+116
New +$29K 0.03% 117